By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Miraculins this week said that it has received gross proceeds of C$554,000 (US$569,000) from the exercise of 5,540,000 warrants through its previously announced warrant exercise incentive program. The firm launched the early-exercise program last month and had targeted the early exercise of up to 7.8 million of its outstanding unlisted warrants.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.